drugset / Trial / NCT04028544
The Study of Qishenyiqi Drop Pills in Improving the Prognosis of Heart Failure Patients
Phase 4
Unknown
5380 enrolled
Chinese Academy of Medical Sciences, Fuwai Hospital
Tianjin Tasly Pharmaceutical Co., Ltd · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a multicenter, randomized, double-blind, placebo-controlled study including patients with ejection fraction decreased heart failure under standardized treatment, to evaluate QiShenYiQi (QSYQ) dropping pill's curative effect in reducing cardiovascular death and heart failure rehospitalization compared with placebo.
Timeline
- Start
- 2019-03-26
- Primary completion
- 2020-09
- Completion
- 2021-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Qishenyiqi dropping pills | Traditional medicine (herbal / TCM) | — | — |